DE69511861D1 - Verfahren zur entfernung von gallsaüre von einem patienten sowie die alkylierte zusammensetzungen dafür - Google Patents

Verfahren zur entfernung von gallsaüre von einem patienten sowie die alkylierte zusammensetzungen dafür

Info

Publication number
DE69511861D1
DE69511861D1 DE69511861T DE69511861T DE69511861D1 DE 69511861 D1 DE69511861 D1 DE 69511861D1 DE 69511861 T DE69511861 T DE 69511861T DE 69511861 T DE69511861 T DE 69511861T DE 69511861 D1 DE69511861 D1 DE 69511861D1
Authority
DE
Germany
Prior art keywords
patient
reaction product
alkylating agent
gallic acid
ch2ch2
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69511861T
Other languages
English (en)
Other versions
DE122004000034I2 (de
DE69511861T2 (de
Inventor
W Mandeville
Stephen Holmes-Farley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Geltex Pharmaceuticals Inc
Original Assignee
Geltex Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22980525&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69511861(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Geltex Pharmaceuticals Inc filed Critical Geltex Pharmaceuticals Inc
Publication of DE69511861D1 publication Critical patent/DE69511861D1/de
Application granted granted Critical
Publication of DE69511861T2 publication Critical patent/DE69511861T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/52—Amides or imides
    • C08F220/54—Amides, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide
    • C08F220/60—Amides, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide containing nitrogen in addition to the carbonamido nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F26/00—Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment
    • C08F8/02—Alkylation
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment
    • C08F8/44—Preparation of metal salts or ammonium salts
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L39/00—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions of derivatives of such polymers
    • C08L39/02—Homopolymers or copolymers of vinylamine
DE69511861T 1994-06-10 1995-06-05 Verfahren zur entfernung von gallsaüre von einem patienten sowie die alkylierte zusammensetzungen dafür Expired - Lifetime DE69511861T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25843194A 1994-06-10 1994-06-10
PCT/US1995/007181 WO1995034585A1 (en) 1994-06-10 1995-06-05 Process for removing bile salts from a patient and alkylated compositions therefor

Publications (2)

Publication Number Publication Date
DE69511861D1 true DE69511861D1 (de) 1999-10-07
DE69511861T2 DE69511861T2 (de) 2000-02-10

Family

ID=22980525

Family Applications (3)

Application Number Title Priority Date Filing Date
DE200412000034 Pending DE122004000034I1 (de) 1994-06-10 1995-06-05 Verfahren zur entfernung von Gallsa}re von einem Patienten sowie die alkylierte zusammensetzungen dafür.
DE1995611861 Active DE122004000034I2 (de) 1994-06-10 1995-06-05 Verfahren zur entfernung von Gallsaure von einem Patienten sowie alkylierte zusammensetzungen dafür
DE69511861T Expired - Lifetime DE69511861T2 (de) 1994-06-10 1995-06-05 Verfahren zur entfernung von gallsaüre von einem patienten sowie die alkylierte zusammensetzungen dafür

Family Applications Before (2)

Application Number Title Priority Date Filing Date
DE200412000034 Pending DE122004000034I1 (de) 1994-06-10 1995-06-05 Verfahren zur entfernung von Gallsa}re von einem Patienten sowie die alkylierte zusammensetzungen dafür.
DE1995611861 Active DE122004000034I2 (de) 1994-06-10 1995-06-05 Verfahren zur entfernung von Gallsaure von einem Patienten sowie alkylierte zusammensetzungen dafür

Country Status (21)

Country Link
US (12) US5679717A (de)
EP (2) EP0764174B1 (de)
JP (1) JP3931217B2 (de)
KR (1) KR100271693B1 (de)
CN (1) CN1150217C (de)
AT (1) ATE184027T1 (de)
AU (1) AU698752C (de)
CA (1) CA2191478C (de)
DE (3) DE122004000034I1 (de)
DK (1) DK0764174T3 (de)
ES (1) ES2135743T3 (de)
FR (1) FR04C0021I2 (de)
GR (1) GR3031702T3 (de)
IL (2) IL114073A (de)
LU (1) LU91100I2 (de)
MX (1) MX9606171A (de)
NL (1) NL300159I2 (de)
NZ (1) NZ288076A (de)
RU (1) RU2160742C2 (de)
TW (1) TW474813B (de)
WO (1) WO1995034585A1 (de)

Families Citing this family (130)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5487888A (en) * 1993-05-20 1996-01-30 Geltex, Inc. Iron-binding polymers for oral administration
US5607669A (en) * 1994-06-10 1997-03-04 Geltex Pharmaceuticals, Inc. Amine polymer sequestrant and method of cholesterol depletion
US5929184A (en) * 1993-06-02 1999-07-27 Geltex Pharmaceuticals, Inc. Hydrophilic nonamine-containing and amine-containing copolymers and their use as bile acid sequestrants
US6129910A (en) * 1993-06-02 2000-10-10 Geltex Pharmaceuticals, Inc. Water-insoluble noncrosslinked bile acid sequestrants
TW474813B (en) * 1994-06-10 2002-02-01 Geltex Pharma Inc Alkylated composition for removing bile salts from a patient
US6203785B1 (en) 1996-12-30 2001-03-20 Geltex Pharmaceuticals, Inc. Poly(diallylamine)-based bile acid sequestrants
US5925379A (en) * 1997-03-27 1999-07-20 Geltex Pharmaceuticals, Inc. Interpenetrating polymer networks for sequestration of bile acids
US6423754B1 (en) 1997-06-18 2002-07-23 Geltex Pharmaceuticals, Inc. Method for treating hypercholesterolemia with polyallylamine polymers
US6083497A (en) * 1997-11-05 2000-07-04 Geltex Pharmaceuticals, Inc. Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers
US6566407B2 (en) 1997-11-05 2003-05-20 Geltex Pharmaceuticals, Inc. Method for reducing oxalate
US6726905B1 (en) 1997-11-05 2004-04-27 Genzyme Corporation Poly (diallylamines)-based phosphate binders
US5985938A (en) 1997-11-05 1999-11-16 Geltex Pharmaceuticals, Inc. Method for reducing oxalate
US6264937B1 (en) * 1998-01-09 2001-07-24 Geltex Pharmaceuticals, Inc. Fat-binding polymers
US6299868B1 (en) 1999-07-14 2001-10-09 Geltex Pharmaceuticals, Inc. Fat-binding polymers
US7048917B1 (en) 1998-01-09 2006-05-23 Genzyme Corporation Fat-binding polymers
US6267952B1 (en) 1998-01-09 2001-07-31 Geltex Pharmaceuticals, Inc. Lipase inhibiting polymers
US6294163B1 (en) 1998-10-02 2001-09-25 Geltex Pharmaceuticals, Inc. Polymers containing guanidinium groups as bile acid sequestrants
TW568788B (en) * 1998-10-12 2004-01-01 Chugai Pharmaceutical Co Ltd Polymer combining with phosphoric acid and preparation containing the same
JP4749649B2 (ja) * 1998-10-12 2011-08-17 中外製薬株式会社 リン酸結合性ポリマー
DE19850817A1 (de) * 1998-11-04 2000-05-11 Basf Ag Modifizierte kationische Polymere, Verfahren zu ihrer Herstellung und ihre Verwendung bei der Papierherstellung
US6271264B1 (en) 1998-12-01 2001-08-07 Geltex Pharmaceuticals, Inc. Polymers containing spirobicyclic ammonium moieties as bile acid sequestrants
ATE366264T1 (de) 1999-04-16 2007-07-15 Abbott Lab Verfahren zur herstellung von vernetzten polyallyaminderivaten
US6190649B1 (en) 1999-04-23 2001-02-20 Geltex Pharmaceuticals, Inc. Polyether-based bile acid sequestrants
CA2379308A1 (en) * 1999-07-14 2001-01-25 Geltex Pharmaceuticals, Inc. Fat-binding polymers, optionally combined with lipase inhibitors
US6180754B1 (en) 1999-09-03 2001-01-30 The Dow Chemical Company Process for producing cross-linked polyallylamine polymer
US6362266B1 (en) 1999-09-03 2002-03-26 The Dow Chemical Company Process for reducing cohesiveness of polyallylamine polymer gels during drying
US6733780B1 (en) 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
US20020054903A1 (en) * 1999-10-19 2002-05-09 Joseph Tyler Direct compression polymer tablet core
CZ302087B6 (cs) * 2000-07-28 2010-10-06 F. Hoffmann-La Roche Ag Farmaceutický prípravek obsahující orlistat spolu se sekvestrantem žlucových kyselin pro použití pro lécení a prevenci obezity
EP2324861A1 (de) 2000-11-20 2011-05-25 Sorbent Therapeutics, Inc. In-vivo-Verwendung wasserabsorbierender Polymere
US8263112B2 (en) * 2000-11-20 2012-09-11 Sorbent Therapeutics, Inc. In vivo use of water absorbent polymers
DE60142527D1 (de) 2000-11-28 2010-08-19 Mitsubishi Tanabe Pharma Corp Exkretionsbeschleuniger für eine akkumulative chlorverbindung
AT409630B (de) 2000-12-13 2002-09-25 Dsm Fine Chem Austria Gmbh Alkylierung von n-bzw. amino- oder ammoniumgruppen haltigen, vernetzten polymeren
WO2002066543A1 (en) * 2001-02-16 2002-08-29 Genzyme Corporation Method of drying a material having a cohesive phase
EP1923064B1 (de) 2001-04-18 2017-06-28 Genzyme Corporation Verwendung von Aminpolymeren zur Minderung des Serumglukosegehaltes
WO2002085380A1 (en) * 2001-04-18 2002-10-31 Geltex Pharmaceuticals, Inc. Method for treating gout and reducing serum uric acid
AU2002257147B9 (en) * 2001-04-18 2005-08-18 Genzyme Corporation Methods of treating syndrome X with aliphatic polyamines
WO2002085379A1 (en) * 2001-04-18 2002-10-31 Geltex Pharmaceuticals, Inc. Method for improving vascular access in patients with vascular shunts
JP5170932B2 (ja) * 2001-04-18 2013-03-27 ジェンザイム コーポレーション 低塩形態のポリアリルアミン
DE60225908T2 (de) * 2001-04-18 2009-05-14 Genzyme Corp., Cambridge Verwendung von colesevelam oder sevelamerhydrogenchlorid zur minderung des serumglukosegehaltes
US7049345B2 (en) * 2001-06-29 2006-05-23 Genzyme Corporation Fat-binding polymers
US7041280B2 (en) * 2001-06-29 2006-05-09 Genzyme Corporation Aryl boronate functionalized polymers for treating obesity
US6600011B2 (en) 2001-10-09 2003-07-29 Genzyme Corporation Process for purification and drying of polymer hydrogels
AT411463B (de) 2002-09-03 2004-01-26 Dsm Fine Chem Austria Gmbh Verfahren zur herstellung von alkylierten n- bzw. amino-, ammonium- oder spirobicyclischen ammoniumgruppen haltigen, vernetzten polymeren
AT414237B (de) * 2002-09-03 2006-10-15 Dsm Fine Chem Austria Gmbh Verfahren zur herstellung von quaternären halogen-alkyl-ammoniumsalzen
AU2003282867A1 (en) * 2002-10-22 2004-05-13 Genzyme Corporation Amine polymers for promoting bone formation
EP1658283A2 (de) 2003-05-30 2006-05-24 Ranbaxy Laboratories, Ltd. Substituierte pyrrolderivate und deren verwendung als hmg-co-inhibitoren
US7335795B2 (en) * 2004-03-22 2008-02-26 Ilypsa, Inc. Crosslinked amine polymers
US7608674B2 (en) * 2003-11-03 2009-10-27 Ilypsa, Inc. Pharmaceutical compositions comprising cross-linked small molecule amine polymers
US7767768B2 (en) * 2003-11-03 2010-08-03 Ilypsa, Inc. Crosslinked amine polymers
US7449605B2 (en) * 2003-11-03 2008-11-11 Ilypsa, Inc. Crosslinked amine polymers
US7459502B2 (en) * 2003-11-03 2008-12-02 Ilypsa, Inc. Pharmaceutical compositions comprising crosslinked polyamine polymers
US7385012B2 (en) * 2003-11-03 2008-06-10 Ilypsa, Inc. Polyamine polymers
CA2560927C (en) 2004-03-26 2013-05-14 Mitsubishi Pharma Corporation Insulin resistance-improving agent
US7854924B2 (en) 2004-03-30 2010-12-21 Relypsa, Inc. Methods and compositions for treatment of ion imbalances
GB2430367B (en) 2004-03-30 2009-08-05 Ilypsa Inc Ion binding polymers and uses thereof
US8282960B2 (en) * 2004-03-30 2012-10-09 Relypsa, Inc. Ion binding compositions
US8192758B2 (en) * 2004-03-30 2012-06-05 Relypsa, Inc. Ion binding compositions
US7556799B2 (en) * 2004-03-30 2009-07-07 Relypsa, Inc. Ion binding polymers and uses thereof
US7429394B2 (en) * 2004-03-30 2008-09-30 Relypsa, Inc. Ion binding compositions
WO2006015594A1 (en) * 2004-08-12 2006-02-16 Versamatrix A/S Beaded and cross-linked poly(aminoalkylene) matrix and uses thereof
DE602005026819D1 (de) * 2004-08-27 2011-04-21 Novo Nordisk As Funktionelles harz mit hoher beladung
JP2008510861A (ja) * 2004-08-27 2008-04-10 ヴァーサマトリックス・アクティーゼルスカブ ポリエーテルポリマーマトリックス
US20060177415A1 (en) * 2004-11-01 2006-08-10 Burke Steven K Once a day formulation for phosphate binders
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
JP4547620B2 (ja) * 2004-12-02 2010-09-22 日東紡績株式会社 架橋アリルアミン類重合体の製造方法
MY144940A (en) * 2005-01-25 2011-11-30 Avantor Performance Mat Inc Chromatographic media
CA2601236A1 (en) * 2005-03-16 2006-09-21 Usv Limited An improved process for the preparation of crosslinked polyallylamine polymer
US8986669B2 (en) 2005-09-02 2015-03-24 Genzyme Corporation Method for removing phosphate and polymer used therefore
AR056499A1 (es) * 2005-09-06 2007-10-10 Serapis Farmaceuticals Ltd Compuestos
JP5595660B2 (ja) 2005-09-15 2014-09-24 ジェンザイム コーポレーション アミンポリマー用サシェ製剤
AU2006294455B2 (en) * 2005-09-30 2013-06-20 Relypsa, Inc. Methods for preparing core-shell composites having cross-linked shells and core-shell composites resulting therefrom
CN101316601A (zh) 2005-09-30 2008-12-03 伊立普萨公司 从哺乳动物的胃肠道选择性除去钾离子的方法和组合物
BRPI0618379A2 (pt) 2005-11-08 2011-08-30 Ranbaxy Lab Ltd processo para preparação do hemi-sal de cálcio do ácido (3r,5r) -7-[2-(4-fluorofenil)-5-isopropil-3-fenil-4-[(4-hidroxime tilfenilamino) carbonil]-pirrol-1-il] -3, 5-diidroxi heptanóico
WO2007130463A2 (en) * 2006-05-05 2007-11-15 Genzyme Corporation Amine condensation polymers as phosphate sequestrants
JP5147695B2 (ja) 2006-06-16 2013-02-20 田辺三菱製薬株式会社 糸球体疾患の予防及び／または治療剤
FR2902799B1 (fr) 2006-06-27 2012-10-26 Millipore Corp Procede et unite de preparation d'un echantillon pour l'analyse microbiologique d'un liquide
EP2041261A4 (de) * 2006-07-13 2012-07-04 Ass For Public Health Services Impfösenkonstruktion
CA2658338A1 (en) * 2006-07-18 2008-01-24 Genzyme Corporation Amine dendrimers
US8425887B2 (en) 2006-09-29 2013-04-23 Genzyme Corporation Amide dendrimer compositions
JP2010513271A (ja) 2006-12-14 2010-04-30 ゲンズイメ コーポレーション アミド−アミンポリマー組成物
US8362217B2 (en) 2006-12-21 2013-01-29 Emd Millipore Corporation Purification of proteins
US8163886B2 (en) 2006-12-21 2012-04-24 Emd Millipore Corporation Purification of proteins
US8569464B2 (en) 2006-12-21 2013-10-29 Emd Millipore Corporation Purification of proteins
US20100129309A1 (en) * 2007-02-23 2010-05-27 Dhal Pradeep K Amine polymer compositions
JP2010520285A (ja) * 2007-03-08 2010-06-10 ゲンズイメ コーポレーション スルホンポリマー組成物
JP2010525061A (ja) * 2007-04-27 2010-07-22 ゲンズイメ コーポレーション アミドアミンデンドリマー組成物
EP2016947A1 (de) 2007-07-17 2009-01-21 Chemo Ibérica, S.A. Neuartiges Verfahren zur Herstellung vernetzter Poly(allylamin-)Polymere in einem einzigen Schritt
JP2011506449A (ja) * 2007-12-14 2011-03-03 ジェンザイム コーポレーション コーティング医薬組成物
PA8807201A1 (es) * 2007-12-14 2009-07-23 Genzyme Corp Composiciones farmaceuticas
WO2009151514A1 (en) 2008-06-11 2009-12-17 Millipore Corporation Stirred tank bioreactor
US20110142952A1 (en) * 2008-06-20 2011-06-16 Harris David J Pharmaceutical Compositions
DE102008030046A1 (de) 2008-06-25 2009-12-31 Ratiopharm Gmbh Kompaktiertes Polyallylamin-Polymer
US8337824B2 (en) 2008-08-22 2012-12-25 Relypsa, Inc. Linear polyol stabilized polyfluoroacrylate compositions
EP2365988B2 (de) * 2008-08-22 2019-07-03 Vifor (International) Ltd. Vernetzte kationenaustauschpolymere, zusammensetzungen und verwendung bei der behandlung von hyperkalämie
US20100104527A1 (en) * 2008-08-22 2010-04-29 Relypsa, Inc. Treating hyperkalemia with crosslinked cation exchange polymers of improved physical properties
CA2735962A1 (en) * 2008-09-02 2010-04-15 Usv Limited Crosslinked polymers
WO2010062734A1 (en) * 2008-11-03 2010-06-03 University Of Maryland, Baltimore Blood coagulation inducing polymer hydrogel
US8404784B2 (en) * 2008-12-03 2013-03-26 Navinta Llc Manufacturing process of making polymeric amine salts
WO2010074953A1 (en) 2008-12-16 2010-07-01 Millipore Corporation Stirred tank reactor and method
US8673272B2 (en) * 2009-07-27 2014-03-18 Isp Investments Inc. Ultraviolet-absorbing compounds
GB0915449D0 (en) * 2009-09-04 2009-10-07 Univ Robert Gordon Composition
CA2790901C (en) * 2010-02-24 2018-05-01 Relypsa, Inc. Amine polymers for use as bile acid sequestrants
CN102858817B (zh) 2010-02-24 2015-09-02 瑞立普萨公司 用作胆汁酸螯合剂的交联聚乙烯胺、聚烯丙胺和乙烯亚胺
US8691918B2 (en) * 2010-05-17 2014-04-08 Emd Millipore Corporation Stimulus responsive polymers for the purification of biomolecules
TR201005327A2 (tr) 2010-06-30 2012-01-23 Bi̇lgi̇ç Mahmut Sinerjik farmasötik formülasyonlar.
US20130156720A1 (en) 2010-08-27 2013-06-20 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
DK2637646T3 (en) 2010-11-08 2016-08-29 Albireo Ab PHARMACEUTICAL COMBINATION CONTAINING AN IBAT inhibitor and a bile acid binder
ME02554B (de) 2010-11-08 2017-02-20 Albireo Ab Ibat-hemmer zur behandlung von lebererkrankungen
ES2633766T3 (es) 2011-10-28 2017-09-25 Lumena Pharmaceuticals Llc Inhibidores de reciclaje de ácido biliar para el tratamiento de enfermedades de hígado colestático pediátrico
US20130123433A1 (en) 2011-11-14 2013-05-16 Formosa Laboratories, Inc. Method for preparing poly(allylamine) hydrochloride and derivatives therefrom
AU2013329451B2 (en) 2012-10-08 2018-08-09 Vifor (International) Ltd. Potassium-binding agents for treating hypertension and hyperkalemia
ES2471340B1 (es) 2012-12-21 2015-08-17 Laboratorios Rubió, S.A. Composición farmacéutica oral para fármacos de elevada posología
US20160083343A1 (en) * 2013-03-15 2016-03-24 Global Blood Therapeutics, Inc Compounds and uses thereof for the modulation of hemoglobin
CN103446179B (zh) * 2013-05-14 2017-03-15 厦门绿洲安源投资管理有限公司 作为磷酸盐、脂肪酸和胆汁酸绑定螯合剂的双亲聚富勒烯树状交联聚阳离子凝胶的应用
ES2834485T3 (es) 2013-06-05 2021-06-17 Tricida Inc Polímeros de unión a protones para administración oral
US9475891B2 (en) 2013-09-19 2016-10-25 Navinta, Llc Process for the preparation of colesevelam hydrochloride
EP2875807B1 (de) 2013-11-20 2021-03-24 Sanovel Ilac Sanayi ve Ticaret A.S. Tablettenformulierung von colesevelam
ITMI20132132A1 (it) 2013-12-19 2015-06-20 Chemi Spa Processo per la preparazione di colesevelam
CA2952223C (en) 2014-06-13 2023-08-01 United Therapeutics Corporation Treprostinil formulations
CA3205149A1 (en) 2014-12-10 2016-06-16 Tricida, Inc. Proton-binding polymers for oral administration
WO2016135065A1 (en) 2015-02-23 2016-09-01 Amneal Pharmaceuticals Company Gmbh Process for granulating sevelamer carbonate
EP3689925B1 (de) 2015-10-21 2022-11-30 Saudi Arabian Oil Company Verfahren zur herstellung eines mesoporösen zeoliths
CN116211887A (zh) 2016-05-06 2023-06-06 特里赛达公司 用于治疗酸碱失衡的组合物
CN106008813B (zh) * 2016-06-15 2017-11-14 新发药业有限公司 溶液聚合制备盐酸考来维仑的方法
JP7418211B2 (ja) 2016-12-14 2024-01-19 エコラブ ユーエスエイ インク 四級カチオン性ポリマー
CN107232191B (zh) * 2017-06-22 2021-05-18 华中师范大学 一种全氟丁基改性聚乙烯亚胺大分子含氟表面活性剂及其制备与在农药缓释中的应用
CA3080651A1 (en) 2017-11-03 2019-05-09 Tricida, Inc. Compositions for and method of treating acid-base disorders
WO2019241056A1 (en) 2018-06-12 2019-12-19 Ecolab Usa Inc. Quaternary cationic surfactants and polymers for use as release and coating modifying agents in creping and tissue papers
CN112047854B (zh) * 2020-10-20 2021-07-02 中国科学院长春应用化学研究所 一种n-乙烯基烷基酰胺的制备方法

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE580490A (fr) * 1958-07-15 1960-01-08 Merck & Co Inc Compositions et procédés pour abaisser la teneur en cholestérol du sang
US3383281A (en) * 1961-09-22 1968-05-14 Merck & Co Inc Method for binding bile acids in vivo
US3308020A (en) * 1961-09-22 1967-03-07 Merck & Co Inc Compositions and method for binding bile acids in vivo including hypocholesteremics
US3288770A (en) * 1962-12-14 1966-11-29 Peninsular Chem Res Inc Water soluble quaternary ammonium polymers
BE756035A (fr) * 1969-09-12 1971-03-11 Inveresk Res Int Polymeres pontes
US3803237A (en) * 1969-11-03 1974-04-09 Upjohn Co Reaction products of polyethylenepolyamines and chlorohydrins or epoxy containing compounds
NL7017227A (de) * 1969-12-27 1971-06-29
US3692895A (en) * 1970-09-08 1972-09-19 Norman A Nelson Method of reducing hypercholesteremia in humans employing a copolymer of polyethylenepolyamine and a bifunctional substance, such as epichlorohydria
US3980770A (en) * 1971-06-04 1976-09-14 Pharmacia Aktiebolag Polymerization products containing amino groups useful in serum cholesterol level control
AR206390A1 (es) * 1973-02-05 1976-07-23 Rohm & Haas Una matriz de resina polimerica reticulada y procedimiento para su preparacion
US4217429A (en) * 1973-06-11 1980-08-12 Merck & Co., Inc. Poly-[(methylimino)trimethylene]
US4027009A (en) * 1973-06-11 1977-05-31 Merck & Co., Inc. Compositions and methods for depressing blood serum cholesterol
US4205064A (en) * 1973-06-11 1980-05-27 Merck & Co., Inc. Bile acid sequestering composition containing poly[{alkyl-(3-ammoniopropyl)imino}-trimethylenedihalides]
CS187563B1 (en) * 1974-02-08 1979-02-28 Petr Strop Method of preparation of the hydrophilic homogeneous or macroporous annexes
CS173201B1 (de) * 1974-02-13 1977-02-28
US4016209A (en) * 1975-04-23 1977-04-05 Merck & Co., Inc. 3-[N'-(3-Halopropyl)-N-'-methylamino]-N,N,N-trimethyl-1-propanaminium halide and acid addition salts thereof
US4101478A (en) * 1976-04-12 1978-07-18 Kostjuchenko Vladimir Mitrofan Synthetic rubber mix
US4071478A (en) * 1976-06-07 1978-01-31 Merck & Co., Inc. Controlled partially cross-linked 3,3-ionenes
FI67483C (fi) * 1977-02-17 1985-04-10 Merck & Co Inc Foerfarande foer framstaellning av ett icke adhesivt friflytande farmakologiskt godtagbart gallsyrakomplexbildande adsorbatpreparat
US4298715A (en) * 1978-03-01 1981-11-03 Monsanto Company Polyamine/epihalohydrin reaction products
JPS5566513A (en) * 1978-11-14 1980-05-20 Ono Pharmaceut Co Ltd Drug for arteriosclerosis comprising high polymer compound as active constituent
IT1106718B (it) * 1978-12-21 1985-11-18 Alfa Farmaceutici Spa Composizioni a base di resine anioniche salificate farmacologicamente attive
DE3272059D1 (en) * 1982-01-18 1986-08-28 Mitsubishi Petrochemical Co Cholesterol lowering drug
JPS6090243A (ja) * 1983-10-25 1985-05-21 Nitto Boseki Co Ltd 小球状モノアリルアミン橋かけ重合体の製造方法
AU551886B2 (en) * 1983-11-14 1986-05-15 Nitto Boseki Co. Ltd. Poly(allylamine) derivatives
JPS60106803A (ja) * 1983-11-14 1985-06-12 Nitto Boseki Co Ltd アリル尿素重合体の製造方法
US4540760A (en) * 1984-01-11 1985-09-10 Nitto Boseki Co. Ltd. Process for producing polymers of monoallylamine
EP0162388B1 (de) * 1984-05-11 1989-09-13 Bristol-Myers Company Galle-Komplexbildner-Harz und seine Verwendung
US4759923A (en) * 1987-06-25 1988-07-26 Hercules Incorporated Process for lowering serum cholesterol using poly(diallylmethylamine) derivatives
US5300566A (en) * 1988-04-15 1994-04-05 Air Products And Chemicals, Inc. Method for preparing poly(vinyl alcohol)-co-poly(vinylamine) via a two-phase process
DE3901527A1 (de) 1989-01-20 1990-07-26 Hoechst Ag Alkylierte polyethyleniminderivate, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel sowie pharmazeutische praeparate
US5236701A (en) * 1989-07-19 1993-08-17 Lowchol Scientific Inc. Ingestible hydrophilic polymeric amines useful for lowering blood cholesterol
GB8928278D0 (en) * 1989-12-14 1990-02-21 Smith Kline French Lab Compounds
GB9011332D0 (en) * 1990-05-21 1990-07-11 Smith Kline French Lab Compounds
IE914179A1 (en) * 1990-12-07 1992-06-17 Ici Plc Nitrogen derivatives
US5055197A (en) * 1991-04-05 1991-10-08 Rohm And Haas Company Process for removing residual monomers and oligemers from amine-containing polymers
US5142019A (en) * 1991-10-03 1992-08-25 Ppg Industries, Inc. Oligomers formed from reaction of acrylamidoglycolate alkyl ethers with β-hydroxyalkylamines
DK0580078T3 (da) * 1992-07-22 1998-05-25 Hoechst Ag Polyvinylamin-derivater med hydrofyle centrer,fremgangsmåde til deres fremstilling samt anvendelse af forbindelserne som lægemidler, bærere af aktive stoffer og næringsmiddelhjælpestof.
ATE146193T1 (de) * 1992-07-22 1996-12-15 Hoechst Ag Vernetzte, stickstoffhaltige vinylcopolymere, verfahren zu ihrer herstellung sowie die verwendung dieser verbindungen
JP3412842B2 (ja) * 1992-07-28 2003-06-03 ミヨシ油脂株式会社 金属捕集剤及びその製造方法
ES2118254T3 (es) * 1992-08-20 1998-09-16 Du Pont Sales de amonio polimericas reticuladas.
US5451397A (en) * 1992-12-21 1995-09-19 Rohm And Haas Company Bile acid sequestrant
WO1994027620A1 (en) * 1993-06-02 1994-12-08 Geltex Pharmaceuticals, Inc. Compositions and process for removing bile salts
US5624963A (en) 1993-06-02 1997-04-29 Geltex Pharmaceuticals, Inc. Process for removing bile salts from a patient and compositions therefor
US5607669A (en) 1994-06-10 1997-03-04 Geltex Pharmaceuticals, Inc. Amine polymer sequestrant and method of cholesterol depletion
US5703188A (en) 1993-06-02 1997-12-30 Geltex Pharmaceuticals, Inc. Process for removing bile salts from a patient and compositions therefor
US5667775A (en) * 1993-08-11 1997-09-16 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
US5414068A (en) * 1994-01-24 1995-05-09 Rohm And Haas Company Crosslinked anion exchange particles and method for producing the particles
TW474813B (en) * 1994-06-10 2002-02-01 Geltex Pharma Inc Alkylated composition for removing bile salts from a patient

Also Published As

Publication number Publication date
IL114073A (en) 2003-06-24
US7399821B2 (en) 2008-07-15
AU698752B2 (en) 1998-11-05
CN1150217C (zh) 2004-05-19
ES2135743T3 (es) 1999-11-01
DE122004000034I2 (de) 2006-04-27
US20020095002A1 (en) 2002-07-18
FR04C0021I1 (de) 2007-10-26
EP0909768A2 (de) 1999-04-21
AU698752C (en) 2002-08-08
JPH10501842A (ja) 1998-02-17
US20070155950A1 (en) 2007-07-05
US20090155201A1 (en) 2009-06-18
DK0764174T3 (da) 2000-03-27
DE122004000034I1 (de) 2005-02-24
EP0764174B1 (de) 1999-09-01
WO1995034585A1 (en) 1995-12-21
IL142419A0 (en) 2002-03-10
GR3031702T3 (en) 2000-02-29
NZ288076A (en) 1998-08-26
US5693675A (en) 1997-12-02
IL114073A0 (en) 1995-10-31
US20050131161A1 (en) 2005-06-16
CA2191478A1 (en) 1995-12-21
US6225355B1 (en) 2001-05-01
US7101960B2 (en) 2006-09-05
US20040014899A1 (en) 2004-01-22
LU91100I9 (de) 2019-01-29
EP0764174A1 (de) 1997-03-26
TW474813B (en) 2002-02-01
CA2191478C (en) 2007-10-16
EP0909768A3 (de) 2001-01-17
KR100271693B1 (ko) 2000-11-15
US5679717A (en) 1997-10-21
US6066678A (en) 2000-05-23
NL300159I2 (nl) 2004-12-01
LU91100I2 (fr) 2004-11-08
CN1150435A (zh) 1997-05-21
DE69511861T2 (de) 2000-02-10
RU2160742C2 (ru) 2000-12-20
FR04C0021I2 (fr) 2008-05-16
US6433026B2 (en) 2002-08-13
AU2699095A (en) 1996-01-05
JP3931217B2 (ja) 2007-06-13
US5917007A (en) 1999-06-29
US6784254B2 (en) 2004-08-31
US5981693A (en) 1999-11-09
ATE184027T1 (de) 1999-09-15
US20010044519A1 (en) 2001-11-22
NL300159I1 (nl) 2004-11-01
MX9606171A (es) 1998-07-31

Similar Documents

Publication Publication Date Title
DE69511861T2 (de) Verfahren zur entfernung von gallsaüre von einem patienten sowie die alkylierte zusammensetzungen dafür
RU96124807A (ru) Способ удаления из организма человека солей желчных кислот и алкилированные композиции для этого способа
IL133434A0 (en) Polyallylamine polymers for treating hypercholesterolemia
DE69326341T2 (de) Poly-3-hydroxyalkanoate und verfahren zu ihrer herstellung
MX9606172A (es) Polimeros reticulados para retirar sales biliares de un paciente.
EP0835888A3 (de) Unvernetztes Anion-Austauscherharz und diesen enthaltende pharmazeutische Zusammensetzung
CA2106750A1 (en) Alkaline-Containing Photoresist Stripping Compositions Producing Reduced Metal Corrosion with Cross-Linked or Hardened Resist Resins
ATE298322T1 (de) Ss'-bis-(alpha, alpha'-disubstituierte-alpha''- essigsäure)-trithio-carbonate und derivate davon als initiatoren, kettentransfer-verbindung, kettenabbruch-verbindung für kontrollierte radikalische polymerisationen sowie verfahren zu deren herstellung
DE69609642D1 (de) Polymersalze von Dithiocarbamosäure und Anwendungsverfahren
FR2705673B1 (fr) Compositions comportant des dérivés d'acides aminés, leurs procédés de préparation et leurs utilisations.
EP0266906A3 (de) Methode und Zusammensetzung zum Verhindern der Polmerisation eines Acrylesters
EP0330413A3 (de) Verfahren zur Unterdrückung von Krusten, Zusammensetzungen und Verfahren zur Herstellung dieser Zusammensetzungen
PL292220A1 (en) Method op obtaining complex salts of hematporphyrine and its derivatives
KR890006670A (ko) 이소폴리펩티드 및 그의 제조방법
FR2527230B1 (fr) Bains de revetement de zinc, renfermant des brillanteurs formes de derives d'acide a-aminopropionique et de leurs polymeres
ATE78816T1 (de) N-substituierte 3,4-dihydropyrimidinderivate, verfahren zu deren herstellung und diese enthaltende zusammenstellung fuer die behandlung von anordnungen eines kardiovascularen systems.
ES2107562T3 (es) Amidas de acidos alfa-aril-alfa-hidroxi-beta-imidazolinil-propanoicos.